Literature DB >> 7863672

Surfactant replacement therapy--room for improvement.

R J Mason.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7863672      PMCID： PMC1022608     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  19 in total

1.  PRELIMINARY REPORT. THE PULMONARY HYPOPERFUSION SYNDROME.

Authors:  J CHU; J A CLEMENTS; E COTTON; M H KLAUS; A Y SWEET; M A THOMAS; W H TOOLEY
Journal:  Pediatrics       Date:  1965-05       Impact factor: 7.124

2.  A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.

Authors:  J J Cummings; B A Holm; M L Hudak; B B Hudak; W H Ferguson; E A Egan
Journal:  Am Rev Respir Dis       Date:  1992-05

3.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis.

Authors:  L M Nogee; D E de Mello; L P Dehner; H R Colten
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

Review 4.  Pulmonary surfactant therapy.

Authors:  A H Jobe
Journal:  N Engl J Med       Date:  1993-03-25       Impact factor: 91.245

5.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

6.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

Authors:  S F Kuan; K Rust; E Crouch
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.

Authors:  T R Ulich; E S Yi; K Longmuir; S Yin; R Biltz; C F Morris; R M Housley; G F Pierce
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  School-age outcomes in children with birth weights under 750 g.

Authors:  M Hack; H G Taylor; N Klein; R Eiben; C Schatschneider; N Mercuri-Minich
Journal:  N Engl J Med       Date:  1994-09-22       Impact factor: 91.245

9.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

Review 10.  Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.

Authors:  W Seeger; A Günther; H D Walmrath; F Grimminger; H G Lasch
Journal:  Clin Investig       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.